6-bromo-N-(naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide | 1092546-34-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-bromo-N-(naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide
• 英文别名: 6-bromo-N-naphthalen-2-yl-2-pyridin-3-ylquinoline-4-carboxamide
• CAS: 1092546-34-3
• 化学式: C₂₅H₁₆BrN₃O
• 分子量: 454.326
• InChiKey: SYZSHYVQKXQTTJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  30
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  54.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  6-Bromo-2-pyridin-3-ylquinoline-4-carbonyl chloride hydrochloride 、 2-萘胺 在 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 丙酮 为溶剂， 反应 2.0h， 生成 6-bromo-N-(naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide
  参考文献：
  名称：

  Cytochrome P450 2C9 Type II Binding Studies on Quinoline-4-Carboxamide Analogues

  摘要：

  CYP2C9 is a significant P450 protein responsible for drug metabolism. With the increased use of heterocyclic compounds in drug design, a rapid and efficient predrug screening of these potential type II binding compounds is essential to avoid adverse drug reactions. To understand binding modes, we use quinoline-4-carboxamide analogues to study the factors that determine the structure-activity relationships. The results of this study suggest that the more accessible pyridine with the nitrogen para to the linkage can coordinate directly with the ferric heme iron, but this is not seen for the meta or ortho isomers. The pi-cation interaction of the naphthalene moiety and Arg 108 residue may also assist in stabilizing Substrate binding within the active-site cavity. The type II substrate binding affinity is determined by the combination of steric, electrostatic, and hydrophobicity factors; meanwhile, it is enhanced by the strength of lone pair electrons coordination with the heme iron.

  DOI：

  10.1021/jm8011257

文献信息

• Cytochrome P450 2C9 Type II Binding Studies on Quinoline-4-Carboxamide Analogues
  作者：Chi-Chi Peng、Jonathan L. Cape、Tom Rushmore、Gregory J. Crouch、Jeffrey P. Jones

  DOI：10.1021/jm8011257

  日期：2008.12.25

  CYP2C9 is a significant P450 protein responsible for drug metabolism. With the increased use of heterocyclic compounds in drug design, a rapid and efficient predrug screening of these potential type II binding compounds is essential to avoid adverse drug reactions. To understand binding modes, we use quinoline-4-carboxamide analogues to study the factors that determine the structure-activity relationships. The results of this study suggest that the more accessible pyridine with the nitrogen para to the linkage can coordinate directly with the ferric heme iron, but this is not seen for the meta or ortho isomers. The pi-cation interaction of the naphthalene moiety and Arg 108 residue may also assist in stabilizing Substrate binding within the active-site cavity. The type II substrate binding affinity is determined by the combination of steric, electrostatic, and hydrophobicity factors; meanwhile, it is enhanced by the strength of lone pair electrons coordination with the heme iron.